Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

MB Latif, S Shukla, PMR Estrada, SP Ribeiro… - Translational …, 2022 - Elsevier
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …

[PDF][PDF] Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

MB LATIF, S SHUKLA, PMDELRIO ESTRADA… - 2021 - binasss.sa.cr
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has at
present,(November 2021) caused 257 million infections and more than 5.1 million deaths …

Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

MB Latif, S Shukla, PMDR Estrada… - … : the journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …

Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

MB LATIF, S SHUKLA… - Translational …, 2022 - translationalres.com
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …

Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.

MB Latif, S Shukla, PM Del Rio Estrada… - … Research: the Journal …, 2021 - europepmc.org
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …

Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.

MB Latif, S Shukla, PM del Rio Estrada, SP Ribeiro… - 2022 - cabidigitallibrary.org
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …

[HTML][HTML] Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

MB LATIF, S SHUKLA… - Translational …, 2022 - ncbi.nlm.nih.gov
Patients with cancers have been severely affected by the COVID-19 pandemic. This is
highlighted by the adverse outcomes in cancer patients with COVID-19 as well as by the …